SinoMab Bioscience Ltd. Financial Overview
SinoMab Bioscience Ltd.'s market cap is currently HK$2.05B. The company's EPS TTM is HK$-0.055; its P/E ratio is -10.23; SinoMab Bioscience Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
